Cite
HARVARD Citation
Valenzuela, F. et al. (n.d.). Tofacitinib versus etanercept or placebo in patients with moderate to severe chronic plaque psoriasis: patient‐reported outcomes from a Phase 3 study. Journal of the European Academy of Dermatology and Venereology. pp. 1753-1759. [Online].